Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 4/20 | 0.61 |
| ▸ | DPP8 | Q6V1X1 | 3/20 | 0.61 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.61 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.61 |
| ▸ | FAP | Q12884 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.60 |
| ▸ | PKM | P14618 | 1/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.60 |
| ▸ | F2 | P00734 | 4/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21067756 | 1.00 | DPP4 (0.61) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL7102492 | 0.95 | CYP3A4 (0.58) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL7106999 | 0.95 | CYP3A4 (0.58) | DPP4DPP8DPP9DPP7FAP | |
| SCHEMBL23752316 | 0.91 | F2 (0.74) | F2 | |
| SCHEMBL15077024 | 0.91 | F2 (0.74) | F2 | |
| SCHEMBL7148728 | 0.91 | F2 (0.74) | F2 | |
| SCHEMBL7101546 | 0.91 | F2 (0.55) | DPP4DPP8DPP9DPP7FAP | |
| Hydrochloric Acid SCHEMBL7357933 | 0.90 | F2 (0.73) | F2 | |
| Hydrochloric Acid SCHEMBL7147479 | 0.90 | F2 (0.73) | F2 | |
| Hydrochloric Acid SCHEMBL7360853 | 0.90 | DPP4 (0.61) | DPP4DPP8DPP9DPP7FAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11446398-B2 | Regulated biocircuit systems | OBSIDIAN THERAPEUTICS, INC. (US) | 2022-09-20 | — | — | US | disclosed |
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |
| US-20190192691-A1 | REGULATED BIOCIRCUIT SYSTEMS | OBSIDIAN THERAPEUTICS, INC. | 2019-06-27 | — | — | US | disclosed |